Register Now

Overview

The medical management of Chronic Kidney Disease (CKD) has become an integral responsibility of Primary care physicians. The KDIGO guidelines on the long-term care of CKD patients were published in 2024 and will be reviewed in detail with attention to the availability of new pharmacotherapy for nephroprotection. A stepwise approach to slowing the progression of CKD will be presented. An open Q&A session will follow the presentation

Learning Objectives

  • Review the diagnosis and long-term complications of CKD
  • Discuss the concept of Nephroprotection and the physiologic principles that play a role in progressive kidney disease
  • Review the role of RAAS inhibitors, SGLT2 inhibitors, Mineralocorticoid inhibitors and GLP-1 agonists in slowing the progression of CKD
  • Define the important role of potassium binders in achieving maximal nephroprotection